128 related articles for article (PubMed ID: 10892658)
1. [Arg8]-vasopressin-induced responses on coronary and mesenteric arteries of rats with myocardial infarction: the effects of V1a- and V2-receptor antagonists.
Lankhuizen IM; van Veghel R; Saxena PR; Schoemaker RG
J Cardiovasc Pharmacol; 2000 Jul; 36(1):38-44. PubMed ID: 10892658
[TBL] [Abstract][Full Text] [Related]
2. Lack of effect of a selective vasopressin V1A receptor antagonist SR 49,059, on potentiation by vasopressin of adrenoceptor-mediated pressor responses in the rat mesenteric arterial bed.
Heinemann A; Horina G; Stauber RE; Pertl C; Holzer P; Peskar BA
Br J Pharmacol; 1998 Nov; 125(6):1120-7. PubMed ID: 9863637
[TBL] [Abstract][Full Text] [Related]
3. [Arg8]vasopressin-induced responses of the human isolated coronary artery: effects of non-peptide receptor antagonists.
Bax WA; Van der Graaf PH; Stam WB; Bos E; Nisato D; Saxena PR
Eur J Pharmacol; 1995 Oct; 285(2):199-202. PubMed ID: 8566139
[TBL] [Abstract][Full Text] [Related]
4. Vascular and renal effects of vasopressin and its antagonists in conscious rats with chronic myocardial infarction; evidence for receptor shift.
Lankhuizen IM; van Veghel R; Saxena PR; Schoemaker RG
Eur J Pharmacol; 2001 Jul; 423(2-3):195-202. PubMed ID: 11448485
[TBL] [Abstract][Full Text] [Related]
5. V1a- and V2-type vasopressin receptors mediate vasopressin-induced Ca2+ responses in isolated rat supraoptic neurones.
Gouzénes L; Sabatier N; Richard P; Moos FC; Dayanithi G
J Physiol; 1999 Jun; 517 ( Pt 3)(Pt 3):771-9. PubMed ID: 10358117
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of a vasopressin V1 receptor in the isolated human gastric artery.
Calò G; Rizzi A; Traina L; Regoli D
Life Sci; 1997; 60(4-5):PL63-8. PubMed ID: 9010490
[TBL] [Abstract][Full Text] [Related]
7. Vascular effects of [Arg8]vasopressin in the isolated perfused rat kidney.
Barthelmebs M; Krieger JP; Grima M; Nisato D; Imbs JL
Eur J Pharmacol; 1996 Oct; 314(3):325-32. PubMed ID: 8957254
[TBL] [Abstract][Full Text] [Related]
8. Characterization of receptors mediating contraction of the rat isolated small mesenteric artery and aorta to arginine vasopressin and oxytocin.
Stam WB; Van der Graaf PH; Saxena PR
Br J Pharmacol; 1998 Oct; 125(4):865-73. PubMed ID: 9831926
[TBL] [Abstract][Full Text] [Related]
9. Vasopressin-induced facilitation of adrenergic responses in the rat mesenteric artery is V1-receptor dependent.
Streefkerk JO; Pfaffendorf M; van Zwieten PA
Auton Autacoid Pharmacol; 2003 Feb; 23(1):35-41. PubMed ID: 14565536
[TBL] [Abstract][Full Text] [Related]
10. Coronary arterial hyperreactivity and mesenteric arterial hyporeactivity after myocardial infarction in the rat.
Stassen FR; Fazzi GE; Leenders PJ; Smits JF; De Mey JG
J Cardiovasc Pharmacol; 1997 Jun; 29(6):780-8. PubMed ID: 9234659
[TBL] [Abstract][Full Text] [Related]
11. Regional differences in the arterial response to vasopressin: role of endothelial nitric oxide.
García-Villalón AL; Garcia JL; Fernández N; Monge L; Gómez B; Diéguez G
Br J Pharmacol; 1996 Aug; 118(7):1848-54. PubMed ID: 8842453
[TBL] [Abstract][Full Text] [Related]
12. Potentiation by vasopressin of adrenergic vasoconstriction in the rat isolated mesenteric artery.
Noguera I; Medina P; Segarra G; Martínez MC; Aldasoro M; Vila JM; Lluch S
Br J Pharmacol; 1997 Oct; 122(3):431-8. PubMed ID: 9351498
[TBL] [Abstract][Full Text] [Related]
13. Vascular responses to vasopressin antagonists in man and rat.
Burrell LM; Phillips PA; Rolls KA; Buxton BF; Johnston CI; Liu JJ
Clin Sci (Lond); 1994 Oct; 87(4):389-95. PubMed ID: 7834989
[TBL] [Abstract][Full Text] [Related]
14. Effects of the vasopressin V1a receptor antagonist, SR 49059, on the response of human uterine arteries to vasopressin and other vasoactive substances.
Kostrzewska A; Laudanski T; Steinwall M; Bossmar T; Serradeil-Le Gal C; Akerlund M
Acta Obstet Gynecol Scand; 1998 Jan; 77(1):3-7. PubMed ID: 9492709
[TBL] [Abstract][Full Text] [Related]
15. Oxytocin and vasopressin constrict rat isolated uterine resistance arteries by activating vasopressin V1A receptors.
Chen YL; Shepherd C; Spinelli W; Lai FM
Eur J Pharmacol; 1999 Jul; 376(1-2):45-51. PubMed ID: 10440088
[TBL] [Abstract][Full Text] [Related]
16. Potent inhibitory effect of SR 49059, an orally active non-peptide vasopressin VIa receptor antagonist, on human arterial coronary bypass graft.
Liu JJ; Chen JR; Buxton BB; Johnston CI; Burrell LM
Clin Sci (Lond); 1995 Nov; 89(5):481-5. PubMed ID: 8549062
[TBL] [Abstract][Full Text] [Related]
17. Coronary vasoconstriction produced by vasopressin in anesthetized goats. Role of vasopressin V1 and V2 receptors and nitric oxide.
Fernández N; García JL; García-Villalón AL; Monge L; Gómez B; Diéguez G
Eur J Pharmacol; 1998 Jan; 342(2-3):225-33. PubMed ID: 9548390
[TBL] [Abstract][Full Text] [Related]
18. Vasopressin V2 (SR121463A) and V1a (SR49059) receptor antagonists both inhibit desmopressin vasorelaxing activity.
Méchaly I; Laurent F; Portet K; Serrano J; Cros G
Eur J Pharmacol; 1999 Nov; 383(3):287-90. PubMed ID: 10594321
[TBL] [Abstract][Full Text] [Related]
19. Vasopressin receptor subtypes on mesenteric and cremasteric arterioles in rat.
Ishiguro S; Iwasaki T; Miyamoto A; Mori T; Nishio A
Eur J Pharmacol; 2000 Jul; 400(1):121-5. PubMed ID: 10913593
[TBL] [Abstract][Full Text] [Related]
20. Vasopressin constricts outer medullary descending vasa recta isolated from rat kidneys.
Turner MR; Pallone TL
Am J Physiol; 1997 Jan; 272(1 Pt 2):F147-51. PubMed ID: 9039061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
